Results 141 to 150 of about 2,521,326 (308)

Concurrent hysterectomy and bilateral salpingo-oophorectomy during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for non-gynecologic cancers

Gynecologic Oncology Reports, 2020
Hyperthermic intraperitoneal chemotherapy (HIPEC) is a key component of treatment in non-gynecologic peritoneal surface malignancies. As many as 10–15% of patients with a gastrointestinal primary malignancy will present with carcinomatosis.
McKayla J. Riggs, Miranda Lin, Joseph Kim, Prakash Pandalai, Charles S. Dietrich, III   +4 more
doaj  

Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy Improves Survival in Selected Patients with Peritoneal Carcinomatosis from Abdominal and Pelvic Malignancies: Results of 21 Cases [PDF]

, 2008
Xiaojun Yang, Yan Li, Alaa Hammed al-shammaa Hassan, Guoliang Yang, Liu Shaoyang, Yulan Lu, Jingwei Zhang, Y Yonemura   +7 more
openalex   +1 more source

Results of Phase 1 study on cytoreductive radical prostatectomy in men with newly diagnosed metastatic prostate cancer

Prostate International, 2019
Background: Preclinical and retrospective data suggest that cytoreductive radical prostatectomy may benefit a subset of men who present with metastatic prostate cancer (mPCa).
Bertram E. Yuh, Young Suk Kwon, Brian M. Shinder, Eric A. Singer, Thomas L. Jang, Sinae Kim, Mark N. Stein, Tina Mayer, Anna Ferrari, Nara Lee, Rahul R. Parikh, Nora Ruel, Wun-Jae Kim, Shigeo Horie, Seok-Soo Byun, Thomas E. Ahlering, Isaac Yi Kim   +16 more
doaj  

Hyperthermia and Fibrinolytic Therapy Do Not Improve the Beneficial Effect of Radioimmunotherapy Following Cytoreductive Surgery in Rats with Peritoneal Carcinomatosis of Colorectal Origin [PDF]

, 2008
Frits Aarts, Thijs Hendriks, Otto C. Boerman, Wim J.G. Oyen, Robert P. Bleichrodt   +4 more
openalex   +1 more source

Secondary cytoreduction in recurrent ovarian cancer- experience from a tertiary care centre in India

Gynecologic Oncology Reports
Introduction: Ovarian cancer is a disease that presents in advanced stage, due to the absence of any specific or overtly dramatic symptoms. The standard of care is primary debulking surgery, followed by chemotherapy.
Priya Bhati, Anitha Thomas, Rachel George Chandy, Amrita Datta, Dhanya Susan Thomas, Vinotha Thomas, Abraham Peedicayil, Ajit Sebastian   +7 more
doaj  

Predictive model for major complications after extensive abdominal surgery in primary advanced ovarian cancer

International Journal of Women's Health, 2019
Antoni Llueca,1–3 Anna Serra,1–3 Karina Maiocchi,2,4 Katty Delgado,2,5 Rosa Jativa,2,6 Luis Gomez,2,4 Javier Escrig3–5 On behalf of the MUAPOS working group (Multidisciplinary Unit of Abdominal Pelvic Oncology Surgery) 1Department of ...
Llueca A, Serra A, Maiocchi K, Delgado K, Jativa R, Gomez L, Escrig J   +6 more
doaj  

On Round Surgery Diagrams For 3-Manifolds [PDF]

arXiv
We introduce the notion of round surgery diagrams in $S^3$ for representing 3-manifolds similar to Dehn surgery diagrams. We give a correspondence between a certain class of round surgery diagrams and Dehn surgery diagrams for 3-manifolds. As a consequence, we recover Asimov's result, stating that any closed connected oriented 3-manifold can be ...
arxiv  

Perioperative Management for Colorectal Peritoneal Metastases [PDF]

, 2018
Kim, Bradford J., Passot, Guillaume
core   +1 more source

Cytoreductive surgery for patients with recurrent epithelial ovarian carcinoma. [PDF]

, 2007
OBJECTIVE: This study aims to identify favorable preoperative characteristics and examine the impact of secondary cytoreductive surgery on survival for patients with recurrent epithelial ovarian carcinoma.
Hoffman, Mitchel S, MD, Martino, Martin A, MD, Palmer, James M, Sayer, Robyn A, Tebes, Christine C, Tebes, Stephen J, MD   +5 more
core   +1 more source

Pathological PCI as a prognostic marker of survival after neoadjuvant chemotherapy in patients undergoing interval cytoreduction with or without HIPEC in FIGO stage IIIC high grade serous ovarian cancer

Frontiers in Oncology
ObjectiveTo determine the best possible value of pathological PCI (pPCI) as a prognostic marker for survival in high-grade serous epithelial ovarian cancer patients in patients treated with neoadjuvant chemotherapy and interval cytoreductive surgery ...
Snita Sinukumar, Dileep Damodaran, Deepika S., Sanjay Piplani   +3 more
doaj   +1 more source